[1]
|
Zaki N., Mohamed EA., "The estimations of the COVID-19 incubation period: a systematic review of the literature," medRxiv, 2020.
|
[2]
|
WHO, "Coronavirus disease (COVID-19) Pandemic," World Health Organization, 2020.
|
[3]
|
Zaki N., Alashwal H., Ibrahim S., "Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review," Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 14, no. 5, pp. 1133-1142, 2020.
|
[4]
|
Burki TK., "Cancer care in the time of COVID-19," The Lancet, vol. 21, 2020.
|
[5]
|
Zhou F., Yu T., Du R., Fan G., Liu Y., et al. , "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study," The Lancet, p. 1054–1062, 2020.
|
[6]
|
Tricco, AC, Lillie, E, Zarin, W, O'Brien, KK, Colquhoun, H. et al., "PRISMA Extension for Scoping Reviews (PRISMA-ScR) : Checklist and Explanation," Annals of Internal Medicine, vol. 169, no. 7, pp. 467-473, 2018.
|
[7]
|
Wang LL. and Lo K., Chandrasekhar Y., Reas R., Yang J. et. al., "CORD-19: The Covid-19 Open Research Dataset," ArXiv, vol. abs/2004.10706, 2020.
|
[8]
|
Manning CD., Raghavan P., Schütze H., An Introduction to Information Retrieval, Cambridge, UK: Cambridge University Press, 2009.
|
[9]
|
Bernhardsson E., "Annoy," [Online]. Available: https://github.com/spotify/annoy.
|
[10]
|
Higgins JPT, Thomas J., Chandler J., Cumpston M., Li T., Page M.J, Welch VA., Cochrane Handbook for Systematic Reviews of Interventions version 6.0, Cochrane Library, 2019.
|
[11]
|
Shevade S.K., Keerthi S.S., Bhattacharyya C., Murthy K.R.K., "Improvements to the SMO Algorithm for SVM Regression," IEEE Transactions on Neural Networks, vol. 11, no. 5, 2000.
|
[12]
|
Hornik K., HalbertWhite, MS., "Multilayer feedforward networks are universal approximators," Neural Networks, vol. 2, no. 5, pp. 359-366, 1989.
|
[13]
|
Breiman L., "Random Forests," Machine Learning, vol. 45, p. 5–32, 2001.
|
[14]
|
Kira K., Rendell LA., "Practical Approach to Feature Selection," in 9th International Workshop on Machine Learning, 1992.
|
[15]
|
Frank E., Hall MA., and Witten IH., he WEKA Workbench. Online Appendix for "Data Mining: Practical Machine Learning Tools and Techniques, 4, Ed., Morgan Kaufmann, 2016.
|
[16]
|
Liu W., Tao Z., Wang L., Yuan M., Liu K., et al. , "Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease," Chinese Medical Journal, 2020.
|
[17]
|
Huang C., Wang Y., Li X., Ren L., Zhao J., et al., "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China," The Lancet, vol. 395, 2020.
|
[18]
|
Wang D., Hu B., Hu C., Zhu F., Liu X., et al. , "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China," JAMA, vol. 323, no. 11, 2020.
|
[19]
|
Tian J., Yuan X., Xiao J., Zhong Q., Yang C., et al., "Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study," The Lancet, 2020.
|
[20]
|
Zhang JJ., Dong X., Cao YY., et al., "Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China," Allergy, 2020.
|
[21]
|
Guan W., Ni Z., Hu Y., et al., "Clinical characteristics of coronavirus disease 2019 in China," N Engl J Med, 2020.
|
[22]
|
Zhang J., Wang X., Jia X., Li L., Hu K., et al. , "Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China," Clinical Microbiology and Infection, vol. 26, pp. 767-772, 2020.
|
[23]
|
Li X., Xu S., Yu M., Wang K., Tao Y., et al., "Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan," J. Allergy Clin. Immunol., 2020.
|
[24]
|
Zheng F., Tang W., Li H., Huang YX., Xie YL., et al. , "Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha," European Review for Medical and Pharmacological Sciences, vol. 24, pp. 3404-3410, 2020.
|
[25]
|
Feng Y., Ling Y., Bai T., Xie Y., Huang J., et al., "COVID-19 with Different Severities: A Multicenter Study of Clinical Features," American Journal of Respiratory and Critical Care Medicine, vol. 201, no. 11, 2020.
|
[26]
|
Shi Y., Yu X., Zhao H., Wang H., Zhao R., et al., "Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan," Critical Care, vol. 24, no. 108, 2020.
|
[27]
|
Huang R., Zhu L., Xue L., Liu L., Yan X., et al., "Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study," PLoS Negl Trop Dis., vol. 14, no. 5, 2020.
|
[28]
|
Channappanavar R., Fett C., Mack M., Ten Eyck P., Meyerholz DK., Perlman S., "Sex-Based Differences in," J Immunol, vol. 198, no. 10, pp. 4046-4053, 2017.
|
[29]
|
Hu S., Gao R., Liu L., Zhu M., Wang W., Wang Y., et al. , "Summary of the 2018 report on cardiovascular diseases in China," Chin Circ J., vol. 39, no. 209, 2019.
|
[30]
|
Liu Y., Yang Y., Zhang C., Huang F., Wang F., et al., "Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury," Science China Life Sciences, vol. 63, p. 64–374, 2020.
|
[31]
|
Fang L., Karakiulakis G., Rotha M., "Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?," Lancet Respir Med., vol. 8, no. 4, p. e21, 2020.
|
[32]
|
Wan Y., Shang J., Graham R., Baric RS., Li F., "Receptor recognition by novel coronavirus from Wuhan: an analysis based on decadelong structural studies of SARS.," J Virology, 2020.
|
[33]
|
Li XC., Zhang J., Zhuo JL. , "The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.," Pharmacol Res, vol. 125, p. 21–38, 2017.
|
[34]
|
Zhao Q., Meng M., Kumar R., Wu Y., Huang J., et al., "The impact of COPD and smoking history on the severityof COVID‐19 A systemic review and meta‐analysis," Journal of Medical Virology, 2020.
|
[35]
|
Zhou Z., Chen P., Peng H., "Are healthy smokers really healthy?," Tob Induc Dis., vol. 14, no. 35, 2016.
|
[36]
|
Fan Z., Chen L., XinCheng J., Yang J., Tian C., et al. , "Clinical Features of COVID-19-Related Liver Functional Abnormality," Clinical Gastroenterology and Hepatology, vol. 18, no. 7, pp. 1561-1566, 2020.
|
[37]
|
Zhang Y., Zheng L., Liu L., Zhao M., Xiao J., Zhao Q., "Liver impairment in COVID‐19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China," Liver international, 2020.
|
[38]
|
Tonnesen P., Marott JL., Nordestgaard B., Bojesen SE., Lange P., "Secular trends in smoking in relation to prevalent and incident smoking-related disease: A prospective population-based study," Tob Induc Dis., 2019.
|
[39]
|
Lippi G., Henry BM., "Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19)," Eur J Intern Med, vol. 75, pp. 107-108, 2020.
|